Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$15.49 - $25.78 $20,137 - $33,514
-1,300 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$23.0 - $32.19 $460,000 - $643,800
-20,000 Reduced 93.9%
1,300 $33,000
Q1 2019

May 15, 2019

BUY
$13.91 - $31.15 $157,183 - $351,995
11,300 Added 113.0%
21,300 $620,000
Q4 2018

Feb 14, 2019

BUY
$11.6 - $18.7 $116,000 - $187,000
10,000 New
10,000 $131,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.46B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.